2022年欧洲肿瘤内科学会(ESMO)年会

2022年欧洲肿瘤内科学会(ESMO)年会将于2022年9月9-13日在法国巴黎以线上线下结合形式举行，会议由欧洲肿瘤内科学会(ESMO)主办。欧洲肿瘤内科学会年会(ESMO大会)是欧洲最负盛名和最具影响力的肿瘤学会议，每年都有超过30,000名专业人士参加会议；届时来自世界各地的临床医生、研究人员、患者倡导者、记者和制药业人士将齐聚一堂，一起分享了解肿瘤学领域的最新进展，并将科学转化为最佳的癌症患者护理。ESMO大会科学计划将由一个300多名国际专家组成的委员会制定，内容涵盖从基础研究到癌症免疫治疗的最新发现，从肿瘤护理到姑息治疗，从罕见癌症到药物批准，等等。ESMO2022年度大会将成为转化研究、呈现实践变化数据宣和多学科讨论的卓越全球平台，大会将提供优秀的科学教育计划，为代表们提供了丰富的交流意见的机会。（2020ESMO虚拟年会数字：30000余名与会者来自150多个国家/地区；230余位演讲嘉宾；2137份摘要提交）

欧洲肿瘤内科学会（ESMO）成立于1975年，是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会，现在全球160多个国家和地区拥有超过25,000余名会员；ESMO致力于通过宣促进多学科的癌症护理，支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理，尽而为癌症患者提供最佳的护理。

ESMO 2022 - European Society of Medical Oncology (ESMO) Congress
DATE: 9-13 September 2022
VENUE: Paris Expo Porte de Versailles, Paris, France + VIRTUAL(虚拟)

The ESMO Congress 2022 will present the very latest advances in the treatment of cancer and offer an excellent educational programme, with a wealth of opportunities for exchange of ideas among delegates.

The innovative, LIVE Plus, Congress format will offer participants the option to attend in person, in Paris, or online, through a virtual platform, from 9 to 13 September 2022.

ESMO is committed to making the latest scientific data and the highest quality education available to all professionals working in oncology wherever they are based. The ESMO Congress 2022 will offer a return to an in-person experience, accompanied by unique networking opportunities, as well as the convenience of an interactive virtual format for those who may choose to take part from a distance.

摘要征集：

Abstract submission deadlines-征稿截止日期

点此提交摘要>>>Submit Abstract>>>

提交摘要规则>>>ESMO Congress 2022 Abstract Submission Regulations>>>

Outcome notifications-结果通知

Outcome notifications are expected to be made available to first authors by mid-July 2022.

Abstract submission categories-摘要提交类别

*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO 2022 submission regulations and guidelines.

Late-breaking abstracts (LBA)-最新数据摘要

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.

The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to the ESMO 2022.

• A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on 3 May 2022.

Submitters of preliminary versions receiving approval to proceed must submit the final LBA by 9 August 2022, 21:00 CEST (Central European Summer Time).

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ESMO 2022.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

• Background
• Trial design

Please note:

• Recruitment must have already begun or have been completed by the abstract submission deadline of 3 May 2022.
• Abstracts including results or preliminary data will be rejected.
• Trial in Progress abstracts can be accepted for Poster presentation only.
• Encore TiP abstracts will not be accepted.

Publication schedule of accepted abstracts-摘要出版时间

1. All regular abstracts accepted for presentation at ESMO 2022 as Proffered Paper (suffix PP), Mini Oral (suffix MO), Poster (suffix P or TiP) will be published online via the ESMO website at 00:05 CEST on Monday, 5 September 2022.
2. All Late-breaking abstracts accepted for presentation at ESMO 2022 as Proffered Paper (suffix PP) or Mini Oral (suffix MO) will be published online via the ESMO website at 00:05 CEST on Thursday, 8 September 2022.
3. Details regarding ESMO PR activities will be made available two weeks prior to the Congress.

Presentation of accepted abstracts

The ESMO 2022 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Presidential Symposium – Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts, including late-breaking abstracts, will be published online only in the ESMO 2022 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

2021年虚拟年会议数字播报：

Fast Facts: ESMO 2021  

• 22 792 participants, 143 countries
• 70 exhibitors
• 464 invited speakers
• 172 sessions, 21 tracks
• 2845 submitted abstracts

参展联系：[email protected]
Industry Guidelines-招商指南下载 here